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OBJECTIVE — We investigated the incidence of the metabolic syndrome and assessed the
effect of smoking status and weight change on incident metabolic syndrome.
RESEARCH DESIGN AND METHODS — This study included 4,542 men without
metabolic syndrome at baseline who were followed for an average of 3 years. Subjects were
divided into four categories according to smoking status at baseline and at the 3-year follow-up.
RESULTS — The overall incidence of metabolic syndrome was 10.6%: 8.0% in nonsmokers,
7.1% in new smokers, 17.1% in ex-smokers, and 13.9% in sustained smokers (P  0.001). In a
multivariate regression model, ex-smokers had signiﬁcantly increased odds for incident meta-
bolic syndrome with a mean 1.45 (95% CI 1.06–1.98) compared with sustained smokers. This
was no longer signiﬁcant after including weight change.
CONCLUSIONS — Smokingcessationwithin3yearsmaybeahigherriskfactorforincident
metabolic syndrome than sustained smoking, indicating that weight control in ex-smokers is
critical to attenuate the additional risk for incident metabolic syndrome.
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A
sthe number of smokers who quit
cigarette smoking is increasing,
recentresearchhasfocusedonthe
impactofpriorsmokingoncardiometa-
bolicdisorders.Severalepidemiological
studies have reported that smoking ces-
sation is associated with an increased
prevalence of the metabolic syndrome
(1,2) compared with that of nonsmok-
ers. However, the studies were cross-
sectional and could not exactly evaluate
the effects of smoking status on the risk
of incident metabolic syndrome. The
aim of the present study was to investi-
gate the 3-year incidence of metabolic
syndrome in men who did not have
metabolic syndrome at baseline and to
assess the effect of smoking status and
weight change on the risk of incident
metabolic syndrome.
RESEARCH DESIGN AND
METHODS— A total of 5,407 men,
who were inhabitants of either Seoul or
Kyung-giprovince,visitedKangbukSam-
sung Hospital for health examinations in
2002 and 2005. Among them, 4,542 par-
ticipants with a median age of 42 years
who did not have metabolic syndrome in
2002(baselinevisit)wereenrolledforthis
study, and the average follow-up period
was 2.9 years. Medical and medication
history, smoking status (current, ex-, or
nonsmoker), alcohol drinking (3 times
per week), and physical activity (3
times per week) were assessed using the
same standard questionnaires in 2002
and 2005. Metabolic syndrome was de-
ﬁned using the World Health Organiza-
tion–West Paciﬁc Region guidelines (3).
Subjectsweredividedintofourcategories
according to smoking status at baseline
and follow-up: nonsmokers, who never
smoked at baseline or follow-up; new
smokers, who never smoked at baseline
but were currently smoking at follow-up;
ex-smokers, who smoked at baseline but
quit smoking by follow-up; sustained
smokers, who smoked continuously at
baseline and follow-up. Weight change
was categorized as weight loss (loss of 2
kg), stable (loss or gain of 2 kg), or
weight gain (gain of 2 kg).
DataareexpressedasmeansSDfor
continuous variables and percentages for
categorical variables. Multivariate logistic
regression analysis models were used to
investigate whether there was an inde-
pendent association between smoking
status and the risk of incident metabolic
syndrome. Statistical tests were two-
tailed, and P  0.05 was considered
statistically signiﬁcant. All statistical anal-
yses were conducted using SPSS for Win-
dows, version 11.5 (SPSS, Chicago, IL).
This research protocol was approved by
the ethics committee of Kangbuk Sam-
sung Hospital.
RESULTS— The overall incidence of
newmetabolicsyndromewas10.6%(482
of 4,542 individuals); the incidence of
metabolic syndrome was 8.0% in non-
smokers, 7.1% in new smokers, 17.1% in
ex-smokers, and 13.9% in sustained
smokers(P0.001).Theoverallmean
SD weight change was 0.53  2.89 kg;
the weight change within each group was
0.31  2.81 kg in nonsmokers, 0.32 
3.06 kg in new smokers, 1.56  3.12 kg
inex-smokers,and0.732.82kginsus-
tained smokers (P  0.001).
The results of multivariate logistic re-
gression analyses for the association be-
tween smoking status and incident
metabolic syndrome are shown in Table
1. In a logistic regression analysis model
adjustingforage,baselineweight,alcohol
consumption, exercise, and baseline
number of metabolic syndrome compo-
nents, the sustained smokers and ex-
smokers predicted signiﬁcant increased
odds for incident metabolic syndrome of
a mean 1.68 (95% CI 1.33–2.12) and
2.43 (1.80–3.29), respectively, com-
pared with the nonsmokers. In sustained
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syndrome increased with the daily num-
ber and duration of cigarettes smoked
when the nonsmokers were used as a
reference.
Furthermore,theex-smokershadsig-
niﬁcantly increased odds of incident met-
abolic syndrome compared with the
sustained smokers in models 1 and 2 (OR
1.45 [95% CI 1.06–1.98] and 1.44
[1.04–2.00], respectively). In contrast,
this was no longer signiﬁcant in model 3,
which includes weight change (1.22
[0.89–1.68]).
Multivariate stratiﬁed analyses based
on the three categories of weight change
showed that in the stable weight and
weight gain groups, ex-smoking was an
independent risk factor for incident met-
abolic syndrome compared with never-
smoking (2.31 [1.41–3.78] and 2.09
[1.29–3.38], respectively, for model 2).
However, in the weight loss group, ex-
smoking was no longer signiﬁcant.
CONCLUSIONS — Inthis3-yearfol-
low-up study, the ex-smokers and sus-
tained smokers had higher risk of
incident metabolic syndrome, indepen-
dent of multiple covariates, compared
with the nonsmokers. The ex-smokers
showed a higher risk of incident metabolic
syndrome than the sustained smokers
when using the multivariate regression
models excluding weight change, but this
ﬁnding was no longer signiﬁcant after in-
cluding weight changes.
Several studies have reported that
chronic smoking is associated with insu-
lin resistance and the prevalence of the
metabolic syndrome (4,5). The results
fromthepresentstudyareconsistentwith
resultsfrompreviousepidemiologicstud-
ies (1,6). However, the previous studies
were cross-sectional and could not deter-
mine the exact cause-and-effect relation-
ship between cigarette smoking and the
incidence of the metabolic syndrome.
Numerous cross-sectional studies
have reported that cigarette smoking is
negatively associated with body weight
and BMI (7–10). However, several pro-
spective studies (11–13) have reported
conﬂicting results regarding weight change
in relation to smoking cessation in women.
In the present study, sustained smokers
showed more weight gain than nonsmok-
ers. This result may be because sustained
smokers were less physically active and the
majority of them had already smoked for a
long period of time at baseline.
Smoking cessation is known to be as-
sociated with weight gain and metabolic
syndrome (1,2,10). In the present study,
ex-smokers experienced signiﬁcant weight
gain and incident metabolic syndrome,
consistent with previous studies. Further-
more, our results showed that the ex-
smokers were at an even higher risk for
incident metabolic syndrome than the sus-
tained smokers, independent of potential
covariates excluding weight change. How-
ever, this result was no longer statistically
signiﬁcant when including weight change.
This result emphasizes the importance of
weight control in ex-smokers for reducing
the incidence of the metabolic syndrome.
Inconclusion,eithersustainedsmok-
ing or smoking cessation in a 3-year pe-
riod is a risk factor for incident metabolic
syndrome in men, independent of weight
change, compared with nonsmoking
men. In addition, smoking cessation
within 3 years may be a higher risk factor
for incident metabolic syndrome than
sustained smoking. The present study in-
dicates that weight control, especially in
men who stop smoking, is critical to at-
tenuate the additional risk for incident
metabolic syndrome.
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